Volume 17, Number 9—September 2011
Dispatch
Multidrug-Resistant Acinetobacter baumannii in Veterinary Clinics, Germany
Sabrina Zordan
, Ellen Prenger-Berninghoff, Reinhard Weiss, Tanny van der Reijden, Peterhans van den Broek, Georg Baljer, and Lenie Dijkshoorn
, Ellen Prenger-Berninghoff, Reinhard Weiss, Tanny van der Reijden, Peterhans van den Broek, Georg Baljer, and Lenie Dijkshoorn
Table
Resistance profiles of 56 animal Acinetobacter spp. isolates for 19 antimicrobial agents, obtained by CLSI broth microdilution test *
| Profile; no. isolates | Tested antimicrobial agents |
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oxa | Pen | Ctn | Ery | Cli | Chl | Cst | Cvf | Amp | Amc | Tet | Enr | Orb | Dif | Kan | Sxt | Gen | Ipm | Amk | |
| 1; 1 | R | R | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | S |
| 2; 1 | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | R | S | R |
| 3; 28 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | S | S |
| 4; 2 | R | R | R | R | R | R | R | I | R | R | R | R | R | R | R | R | R | S | S |
| 5; 2 | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | R | R | S | S |
| 6; 1 | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | R | S | S |
| 7; 1 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | S | R | R | S | S |
| 8; 1 | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | R | S | S | S |
| 9; 3 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | S | S | S | S |
| 10; 1 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | I | S | S | S | S |
| 11; 1 | R | R | R | R | R | R | R | R | R | R | I | R | R | R | R | S | S | S | S |
| 12; 1 | R | R | R | R | R | R | S | R | R | R | R | R | R | R | R | S | S | S | S |
| 13; 1 | R | R | R | R | R | R | R | R | R | I | R | S | S | S | R | R | R | S | S |
| 14; 3 | R | R | R | R | R | R | R | R | I | I | R | R | R | R | S | S | S | S | S |
| 15; 1 | R | R | R | R | R | R | R | R | I | I | R | R | R | R | S | S | S | S | S |
| 16; 2 | R | R | R | R | R | R | R | R | I | I | S | S | S | S | S | S | S | S | S |
| 17; 1 | R | R | R | R | R | R | R | R | I | S | S | S | S | S | S | S | S | S | S |
| 18; 1 | R | R | R | R | R | R | R | I | I | S | S | S | S | S | S | S | S | S | S |
| 19; 1 | R | R | R | R | R | R | R | R | S | S | S | S | S | S | S | S | S | S | S |
| 20; 1 | R | R | R | R | R | R | R | I | S | S | S | S | S | S | S | S | S | S | S |
| 21; 1 | R | R | R | R | R | R | S | R | S | S | S | S | S | S | S | S | S | S | S |
| 22; 1 | R | R | R | R | R | R | S | I | S | S | S | S | S | S | S | S | S | S | S |
*CLSI guidelines M31-A2 (9). CLSI, Clinical Laboratory Standards Institute; Oxa, oxacillin; Pen, penicillin; Ctn, cephalotin; Ery, erythromycin; Cli, clindamycin; Chl, chloramphenicol; Cst, colistin; Cvf, cefovecin; Amp, ampicillin; Amc, amoxicillin/clavulanic acid; Tet, tetracycline; Enr, enrofloxacin; Orb, orbifloxacin; Dif, difloxacin; Kan, kanamycin; Sxt, trimethoprim/sulfamethoxazole; Gen, gentamicin; Ipm, imipenem; Amk, amikacin; R, resistant; I, intermediate; S, susceptible.
Page created: September 06, 2011
Page updated: September 06, 2011
Page reviewed: September 06, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.